Suzhou Novoprotein Scientific Co (SHSE:688137) Net Income From Continuing Operations : ¥-0.9 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Suzhou Novoprotein Scientific Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Suzhou Novoprotein Scientific Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥-2.6 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.9 Mil.

Suzhou Novoprotein Scientific Co Net Income From Continuing Operations Historical Data

The historical data trend for Suzhou Novoprotein Scientific Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Novoprotein Scientific Co Net Income From Continuing Operations Chart

Suzhou Novoprotein Scientific Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-8.50

83.05

149.01

90.72

12.84

Suzhou Novoprotein Scientific Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial											11.14	1.22	3.52	-3.03	-2.63

Suzhou Novoprotein Scientific Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.9 Mil.

Suzhou Novoprotein Scientific Co (SHSE:688137) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Novoprotein Scientific Co Ltd (SHSE:688137) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 228, Yunchuang Road, 3rd & 4th Floor, Wujiang Economic and Technological Development Zone, Jiangsu Province, Suzhou, CHN, 215299

Website

http://www.novoprotein.com.cn

Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes and reagents, Production and sales, and provide related technical services.

Suzhou Novoprotein Scientific Co (SHSE:688137) Headlines

No Headlines